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CWUTAbstract Acquired cholesteatoma in children is an aggressive disease due to its rapid growth and
high recurrence rate.
Objective: To assess clinical features of cholesteatoma in children and evaluate our experience in
the surgical management of this disease.
Methods: Fourty children aged 5–16 years operated on for acquired middle ear cholesteatoma
(2002–2011), were included in our study. Surgery was bilateral for 3 patients, which makes a total
number of 43 operated ears. Functional and anatomical results were evaluated after a minimum
follow-up of 3 years.
Results: Mean age at the ﬁrst operation was 11.7 years. Canal wall-up tympanoplasty (CWUT)
was performed as ﬁrst-line procedure in 74% of cases. Canal wall-down tympanoplasty (CWDT)
was performed in 26% of cases when cholesteatoma was hardly controllable with a CWUT. Carti-
lage graft was used in all cases for eardrum reinforcement. After a mean interval of 12.2 months,
second look procedure aimed to verify a residual cholesteatoma in 8 cases and perform an ossicu-
loplasty in one case. Total cholesteatoma recurrence rate was 18% with CWUT and 9% with
CWDT (p= 0.4). Predictive factors for recurrence were: children < 10 years (p= 0.02) and ossic-
ular chain resorption (p= 0.04). Post-operative ABG 6 25 dB was seen in 53% of CWUT against
18% of CWDT (p= 0.04).
Conclusion: CWUT is the optimal management technique offering better hearing results, how-
ever, prevention of recurrences are considered to be better with CWDT.
 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Acquired cholesteatoma in children is an aggressive disease
due to its rapid growth and high recurrence rate.1,3 Surgical
management aims to eradicate the disease process, prevent.
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Figure 1 Main symptoms reported by patients.
2 O. Ben Gamra et al.recurrences and preserve auditory function thus preventing
learning difﬁculties.9
The choice of the adequate surgical technique, either canal
wall down tympanoplasty (CWDT) or canal wall up tym-
panoplasty (CWUT) must be determined for each individual
case according to the extent of the cholesteatoma.2,3 CWUT
technique has gained favor among most surgeons for treating
cholesteatomas in the pediatric population. It is currently con-
sidered to be the reference procedure when it is technically
feasible.26
1.1. Objective
To assess clinical features of cholesteatoma in children and
evaluate our experience in the surgical management of this
disease.
2. Methods
We present a retrospective descriptive study (January
2002–December 2011) reviewing a total of 40 children aged
5–16 years, operated on for acquired middle ear cholesteatoma
in our ENT Department.
Preoperatively, all patients had temporal bone tomodensit-
ometry and tonal audiometry. Selection of the applied surgical
technique (CWUT or CWDT) was made according to pre- and
intraoperative ascertainment. CWUT was indicated as a
ﬁrst-line procedure for patients with a large well pneumatized
mastoid and a well-controlled disease. CWDT was performed,
depending on anatomical conditions, when cholesteatoma was
hardly fully controllable with a CWUT technique. A planned
second look surgery was indicated after a mean interval of
12 months to rule out a residual cholesteatoma or perform
an ossiculoplasty if needed. Patients were operated on by four
different surgeons.
The results were evaluated in terms of hearing improvement
and recurrence rate. Preoperative audiometry and the last
available audiometry were analyzed with calculation of air
conduction (AC), bone conduction (BC) thresholds and air-
bone gap (ABG) by averaging thresholds at 500 Hz, 1 kHz
and 2 kHz.
Statistical analysis was performed using SPSS-19. We con-
ducted a descriptive study of quantitative and qualitative vari-
ables, as well as univariate Chi-square study of qualitative
variables. Statistical signiﬁcance was assigned to a p-value of
0.05.
3. Results
Middle ear surgery was bilateral for three patients which
makes a total number of 43 operated ears. For all cases, pri-
mary surgery was done in our institution with a minimum
follow-up period of 3 years.
Mean age at the ﬁrst operation was 11.7 years ranging from
5 to 16 years with a male predominance (sex-ratio of 2.3). A
history of serous otitis media was observed in 2 cases. Among
the cases of bilateral cholesteatoma, two had a cleft palate.
There was no history of eardrum trauma.
The main symptoms reported by our patients were chronic
otorrhea (93%) and hearing loss (72%), evolving for a mean
duration of 38 months (Fig. 1). Four children presented acomplication revealing the disease: acute mastoiditis (2 cases),
facial palsy (1 case) and dizziness due to a labyrinthine ﬁstula
(1 case).
Preoperative otoscopy revealed cholesteatoma in 69%, attic
perforation in 51%, pars ﬂaccida retraction in 25% and an
attic polyp in 25% (Table 1).
Abnormalities in the contralateral ear were observed in 11
ears (25%): attic cholesteatoma (3 cases), attic retraction (4
cases), adhesive otitis (2 cases) and tympanic perforation (2
cases). Nasal endoscopy showed a non-obstructive septal devi-
ation in 3 cases and adenoid vegetations in 7 patients.
Preoperative audiometry revealed a mean air conductive
hearing loss of 40 dB in 32 cases. A mixed hearing loss was
found in 5 cases, with a mean threshold of 50 dB and a mean
ABG of 40 dB. Auditory function was normal in 6 patients.
On CT scan, cholesteatoma extended to the epitympanum
and the antrum in most cases (79%) (Table 2). Ossicular chain
was complete in 25% (n= 11) and eroded in 75% (n= 32).
The incus was the ossicle most frequently lysed (84%), fol-
lowed by the malleus (55%) and the stapes (32%). CT also
revealed complications including a facial canal lysis in 2 cases,
a labyrinthine ﬁstula in one case and a protruding jugular bulb
in another.
Intra operatively, sites involved by cholesteatoma are
detailed in Table 3. Ossicular chain was disturbed in 38 cases
(88%). The ossicle most commonly destroyed was the
incus (86%), followed by the malleus (53%) and the stapes
(46%).
Among our patients, 35 underwent a single operation, 4
were operated twice and one had a third operation. The mean
interval between the ﬁrst two procedures was 12.2 months.
CWUT is the preferred operative technique in our center,
performed in 74% of cases (n= 32). It was indicated for
patients with a large well pneumatized mastoid and a
well-controlled disease. It was combined with a mastoidectomy
in 24 cases (75%) and a posterior tympanotomy in 2 cases
(6%).
CWDT was performed in 26% of cases. It was advocated to
the following ﬁndings: lateral sinus protrusion (6 cases),
meningeal protrusion (3 cases) and extension of cholesteatoma
to the retrotympanum (5 cases). Considering these anatomical
conditions, cholesteatoma was hardly controllable with a
CWUT technique.
One child had a large mesotympanic cholesteatoma extend-
ing to the protympanum, responsible for a labyrinthine ﬁstula
of the lateral semicircular canal (Fig. 3). A CWDT helped to
control the disease, remove the matrix completely and seal
the ﬁstula.
Table 1 Otoscopy ﬁndings.
Otoscopy ﬁndings Number %
Retraction pocket:
Shrapnel membrane 11 25
Posterior 3 7
Perforation:
Attic 22 51
Anterior 6 13
Subototal 1 2
Polyp 11 25
Cholesteatoma 30 69
Table 2 Cholesteatoma extension on CT scan.
Tomodensitometry ﬁndings N %
Mesotympanum+ epitympanum 34 79
Mesotympanum+ mastoid 2 5
Mesotympanum 4 9
Mesotympanum+ mastoid + retrotympanum 1 2
Mesotympanum+ window region + retrotympanum 2 5
Total 43 100
Table 3 Cholesteatoma extension: intraoperative ﬁndings.
Cholesteatoma extension Number
Attic 6
Attic + mesotympanum 9
Attic + hypotympanum 1
Retrotympanum/stapes/window region 12
Attic + mastoid 11
Attic + mesotympanum+ mastoid 4
Total 43
Table 4 Rates of recurrence and residual disease according to
the surgical technique.
Recurrence p Residual p
CWUT (32) 5 (15%) 1 (3%) 0.4
CWDT (11) 0 1 (9%)
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operated on by CWUT after a mean delay of 12.2 months
[11–18 months]. It aimed to verify a residual cholesteatoma
in 8 cases and to perform an ossiculoplasty in one case.
Ossicular reconstruction was possible in 37% (n= 16) dur-
ing the ﬁrst-line procedure and was deferred until the second
procedure in one case. Ossicles were removed during the ﬁrst
procedure in 46% of cases (incus in 32% and head of malleus
in 14%). Reconstruction was carried out by means of columel-
lization with shaped autologous ossicles or cartilage. It con-
sisted of incus transposition in 9 cases, cartilage graft onto
stapes in 6 cases, and titanium total ossicular replacement
prosthesis in 1 case.
For eardrum and canal wall reconstruction, we used total
cartilage in all cases: conchal cartilage in 81% and tragal car-
tilage in 19%.
After a mean follow up period of 44 months [3–10 years],
the total cholesteatoma recurrence rate (residual and recur-
rent) was 16% (n= 7). This rate was not statistically inﬂu-
enced by the surgical technique (Table 4).
Residual disease was detected in 2 cases (CWUT and
CWDT) after a mean delay of 12 months. All recurrences
(n= 5) occurred with CWUT after a mean delay of 22 monthsrequiring subsequent CWDT in 3 cases. These recurrences con-
cerned an attic cholesteatoma extended to the atrium and the
mastoid. Intraoperatively, we found a cholesteatoma invading
the window region (2 cases), a lateral sinus protrusion (2 cases)
and a meningeal protrusion (1 case). For the latter, a second
recurrence occurred after a mean period of 3 years treated by
CWDT.
Recurrence occurred more frequently in children
<10 years, where 80% had recurrence against 28% in older
children (p= 0.02). Also, all patients with recurrent disease
had ossicular chain resorption against 55% with no recidivism
(p= 0.05).
Hearing failure was seen in 11% with a mean loss of 25 dB.
Hearing improvement was observed in 56% with a mean gain
of 15 dB. Auditory function was stable in 33%. Post-operative
ABG 6 25 dB was seen in 41% of cases.
According to the surgical procedure, the mean ﬁnal AC
hearing loss was 8.59 dB in the CWUT group and 20 dB in
the CWDT group (Fig. 2). A post-operative ABG 6 25 dB
was observed in 53% of CWUT against 18% of CWDT
(p= 0.04) concluding to better functional results with CWUT.
There were no cases of sensorineural hearing loss or facial
nerve injury after surgery in our series. However, one patient
developed post-operative infection and another presented a
meatal stenosis due to meatoplasty infection. In both cases,
infection resolved without sequelae after adequate
antibiotherapy.
4. Discussion
Retraction pocket of the tympanic membrane, resulting from
eustachian tube dysfunction is the commonest cause of
acquired cholesteatoma in children.4 These pockets usually
develop in the pars ﬂaccida or the upper posterior part of
the pars tensa.4,16 Mean age at onset varies between 9 and
13 years.1–3,9,31
Most authors believe that cholesteatoma is more aggressive
in children than in adults. Bujı´a5 analyzed the expression of
MIB1 (a monoclonal antibody marker of cell proliferation)
in child and adult cholesteatoma and found a higher prolifer-
ation rate in children. Mobeen6 also conﬁrmed a signiﬁcantly
higher proliferative rate of the cholesteatoma matrix in this
group. In addition, Dornelles24 showed that pediatric speci-
mens expressed higher levels of matrix metalloproteinases
and exhibited an exaggerated inﬂammatory proﬁle.
Temporal bone CT assesses cholesteatoma extension,
explores complications and detects anatomic variants before
surgery.7 Nevertheless, cholesterol granuloma, frequently asso-
ciated with cholesteatoma, cannot be differentiated on CT.7
MRI is indicated for initial extension assessment, in case of
meningeal contact and during follow-up when CT scan is
doubtful.7
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Figure 2 Final air conduction thresholds according to the
surgical technique.
Figure 3 Axial CT scan of the temporal bone showing a large
cholesteatoma responsible for a labyrinthine ﬁstula of the right
lateral semicircular canal.
Table 5 Recurrence rate of cholesteatoma.
Authors Recurrent cholesteatoma
Drahy1 9% (CWUT) 0% (CWDT)
Gocmen2 26% (CWUT) 16% (CWDT)
Soldati14 26% (CWUT) 22% (CWDT)
Schraﬀ9 17% (CWUT) 12% (CWDT)
Hajri37 41% (CWUT) 18% (CWDT)
Our series 18% (CWUT) 9% (CWDT)
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toid and mesotympanum, surgery is more difﬁcult than in
adults and results are considered to be poorer.4 It aims to erad-
icate the disease, preserve or improve hearing and prevent
recurrence or residual disease.9 CWUT is the preferred opera-
tive technique in our center and for most authors.1,2,6,9,16,23,31
It is an adequate surgical option for treating most acquired
cholesteatomas and is currently considered to be the reference
procedure when it is technically feasible.3,33 This technique
allows the use of post-operative hearing aids, rapid healing,
water exposure and preserves the anatomy of the middle
ear.6,9,10,14,23 This approach is widely performed in children
also because of their difﬁculty to manage an open mastoid cav-
ity.31 In our study, the canal wall was preserved in 74% of
cases.
Currently, the main recent advances are represented by the
generalized use of total cartilage graft for tympanoplasty in the
pediatric population.7,17,27 This material should be used for
eardrum reinforcement and also canal wall reconstruction,
given the preponderance of recurrence and retraction pockets
in this age group.7,16,17 The problem encountered with carti-
lage is failure to control retrotympanic liquid effusion.27,28The use of otoendoscopy is of great value in pediatric mid-
dle ear surgery.16 It has advantages of visualization of hidden
areas such as: sinus tympani, facial recess, anterior epitym-
panic space, attic, hypotympanum, medial epitympanum and
retrotympanum.16,18,22,23,31 For some authors, if the disease
is limited to the middle ear and entirely accessible through
the ear canal, it can be removed via an endoscopic permeatal
atticoantrostomy, thus avoiding the disadvantage to the child
of an external incision.11,16,21,23 For Adrian,16 tragus cartilage
is the optimum graft for endoscopic ear surgery because the
incision for access can be hidden on the posterior surface.
On the other hand, CWDT is reserved for large cholestea-
toma that cannot be adequately removed by CWUT, children
with a small mastoid, limited air cells or meningeal prolapse
and patients with poor follow up.1,9,10,31,33 It is associated with
a lower recurrence rate, varying from 13% to 17%.12,13,31,32,36
However, the mastoid cavity is more prone to otorrhea,
requires regular cleaning and causes difﬁculties in applying
hearing aids.9,10,25
Recurrences are more often seen in children than adults and
are most likely to be found in the attic and mesotympa-
num.4,7,18,19 For Schraff,9 75% of recurrences occurred within
the 3 ﬁrst post-operative years. Predictive factors for recur-
rence retained by many authors are: children <8 years, ossic-
ular lysis especially stapes superstructure, large cholesteatoma,
eustachian tube dysfunction and round window or sinus tym-
pani involvement.1,4,8,19,20,29,33,35 Furthermore, Nelson30
reported that the cholesteatoma involving the posterior supe-
rior quadrant or the mastoid recurred more frequently than
the cholesteatoma in anterior mesotympanum. Although many
authors15,17 have shown that the choice of the initial surgical
technique does not signiﬁcantly modify the control of the dis-
ease, Drahy1 reported all recurrences with CWUT (Table 5).
Second look surgery is still controversial. For Schraff9,
staging is systematically done at approximately 6–12 months
after ﬁrst surgery to assess for recurrent cholesteatoma and
ossicular chain reconstruction if needed. For Soldati14, second
surgery was planned for poor hearing results either because the
ossicular chain reconstruction had not been possible at ﬁrst
surgery or because hearing has worsened. Recently, intraoper-
ative use of endoscopes to reduce residual disease rates, as well
as the use of MRI has the potential to reduce the need for
second-look surgery.31
In our institution, second look operation was planned for 9
children operated on by CWUT after a mean delay of
12.2 months. This procedure was performed to rule out a resid-
ual cholesteatoma in 8 cases evaluated by a diffusion-weighted
MRI, and to perform an ossiculoplasty in one case.
Hearing prognosis seems to depend not only on the surgical
technique but also on the disease extension, the condition of
Table 6 Mean post-operative ABG after CWUT and CWDT
reported in some series.
Authors Mean post-operative
ABG (CWUT) (dB)
Mean post-operative
ABG (CWDT) (dB)
Drahy1 16 30
Schraﬀ9 20 33
Darrouzet34 21 31
Our series 29 34
Acquired cholesteatoma in children 5the middle ear mucosa and the stapes superstructure.9,31,33
Indeed, many authors found that patients with CWDT had
less improvement post-operatively compared with children
with the CWUT approach.9,10,33 This was the case in our series
(Table 6).
5. Conclusion
The optimal management of pediatric cholesteatoma remains
challenging because of the high recidivism compared with
adults. According to this study, children aged <10 years and
erosion of the ossicular chain were at risk of recurrence.
CWUT is the optimal management technique offering better
hearing results, however, prevention of recurrences are consid-
ered to be better with CWDT.
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